| NCDs | Non-Communicable Diseases |
| CVDs | Cardiovascular Diseases |
| CRDs | Chronic Respiratory Diseases |
| PEITC | Phenethyl Isothiocyanate |
| LDL | Low-Density Lipoprotein |
| RCT | Randomized Controlled Trial |
| SENO | Standardized Extract of Nasturtium officinale |
| CRP | C-Reactive Protein |
| EENO | Ethanolic Extract of Nasturtium officinale |
| MDA | Malondialdehyde |
| BUN | Blood Urea Nitrogen |
| SOD | Superoxide Dismutase |
| TGs | Triglycerides |
| T2D | Type 2 Diabetes |
| AGEs | Advanced Glycation End-Products |
| RAGEs | Receptor for Advanced Glycation End-Products |
| IRS1 | Insulin Receptor Substrate 1 |
| PI3K | Phosphoinositide 3-Kinase |
| AKT2 | Protein Kinase B (AKT2) pathway |
| BPA | Bisphenol A |
| DBP | Dibutyl Phthalate |
| CAT | Catalase |
| GSH | Glutathione |
| Nrf2 | Nuclear Factor Erythroid 2–Related Factor 2 |
| NF-κB | Nuclear Factor Kappa B |
| IL | Interleukin (e.g., IL-1β, IL-6) |
| TNF-α | Tumor Necrosis Factor-alpha |
| AP-1 | Activator Protein 1 |
| CCL2 | Chemokine (C-C motif) Ligand 2 |
| TMAO | Trimethylamine N-oxide |
| WNT/β-catenin | WNT Signaling Pathway/Beta-catenin |
| ER | Endoplasmic Reticulum |
| IC50 | Half Maximal Inhibitory Concentration |
| PRF | Phenolic-Rich Fraction |
| PhEF | Phenethyl Isothiocyanate-Enriched Extract |
| AuNPs | Gold Nanoparticles |
| PEG-PLGA | Polyethylene Glycol–Polylactic-co-Glycolic Acid |
| NOE-NPs | Nasturtium officinale-Extract Nanoparticles |
| HbA1c | Hemoglobin A1c |
| ALT | Alanine Aminotransferase |
| AST | Aspartate Aminotransferase |
| GLUT4 | Glucose Transporter Type 4 |
| AMPK | AMP-Activated Protein Kinase |
| COPD | Chronic Obstructive Pulmonary Disease |
| GPX | Glutathione Peroxidase |
| SMA-α | Alpha-Smooth Muscle Actin |
| NO | Nitric Oxide |
| FRAP | Ferric Reducing Antioxidant Power |
| Gata3 | Transcription Factor GATA-3 |
| TGF-β1 | Transforming Growth Factor Beta 1 |
| MEITCs | Methyl Isothiocyanates |
| PCOs | Protein Carbonyls |